In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Oxford Biomedica names chief development officer

This article was originally published in Scrip

Executive Summary

Oxford BioMedica, a gene and cell therapy company, has named its non-executive director Dr Paul Blake to its executive management team as chief development officer – effective 1 September 2014. Dr Blake joined the board of Oxford BioMedica in January 2010 and will retain his seat alongside his new position. Most recently, Dr Blake was senior vice-president and chief medical officer of Æterna Zentaris, a global biopharmaceutical company focused on oncology and endocrine therapy.


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts